None listed
Conditions
Brief summary
A study of proteins involved in the inflammation and pain associated with arthritis of the knee The study involves inviting people with a diagnosis of arthritis of the knee to participate in the study. The treatment for their arthritis will not be altered in any way. Participants will be asked to attend a single appointment, which will take about 2 hours and the following will occur: Questions about their health and specifically their arthritis and about any medications they are taking. This will be followed by a physical examination by the doctor (including weight, height, abdominal and waist circumference, BP) Questionnaires about pain, and difficulties/disability caused by the arthritis and associated pain. The knee joint will be examined by a doctor and undergo an ultrasound examination of the knee. The fluid in the knee will be withdrawn through a needle.
Interventions
Sponsors
Eligibility
Inclusion criteria
OA of the knee based on ACR clinical criteria Active gout of the knee RA meeting ACR criteria PsA meeting CASPAR criteria
Exclusion criteria
Contraindication or unwillingness to undergo an US scan Contraindication or unwillingness to undergo arthrocentesis (Including an INR> 2) Diagnosis of septic arthritis, Paget’s disease, articular fracture, ochronosis, acromegaly, haemochromatosis, Wilson’s disease, primary osteochondrosis Injury to the study knee within 6 months of the study start knee joint replacement (partial or total); osteotomy of the studied joint; with arthroscopy of the studied joint made within 1 year of the study start With an intra articular injection of steroids made within 4 weeks and/or intra articular injection of radionuclide made with 3 months prior to study entry